Table 3

Patient Outcomes at 6-Month Follow-up

OutcomePhase 1
(n = 368)
Phase 3
(n = 554)
Effect Estimatea
(95% CI)
P
Valuea
Function and pain
Disability: change in RMDQ score2.2 (6.0)2.7 (5.5)0.71 (0.06 to 1.36)b.03
Achieved MCIDc, No. (%)154 (42)261 (47)1.24 (0.92 to 1.67)d.15
Pain intensity: change in NRS rating1.7 (2.8)1.9 (3.2)0.29 (−0.05 to 0.63)b.09
Physical function: change in SF-12 PCS score−3.7 (11.5)−3.9 (16.3)−0.78 (−2.47 to 0.92)b.35
Psychosocial outcomes
Catastrophizing: change in PCS-CAT score1.7 (8.3)1.8 (10.3)0.28 (−1.13 to 1.68)b.67
Fear avoidance: change in TSK score2.5 (8.3)3.6 (11.2)1.58 (0.53 to 2.62)b.006
Anxiety: change in HADS subscale score1.0 (44)1.2 (4.7)0.34 (−0.29 to 0.97)b.27
Depression: change in HADS subscale score1.0 (40)1.4 (3.7)0.46 (−0.07 to 0.98)b.08
Mental health: change in SF12 MCS score−1.9 (14.3)−2.1 (13.7)−0.56 (−2.77 to 1.64)b.58
Pain self-efficacy: change in PSEQ score−7.6 (12.8)−7.2 (15.5)−0.45 (−2.16 to 1.26)b.60
Global change from baseline, No. (%)
Completely recovered38 (10)63 (11)1.22 (0.93 to 1.59)d.16
Much better102 (28)178 (32)
Better88 (24)129 (23)
No change95 (26)127 (23)
Worse/much worse45 (12)57 (10)
Risk group, No. (%)
Low240 (65)404 (73)1.49 (1.05 to 2.12)d.03
Medium96 (26)122 (22)
High32 (9)28 (5)
Work losse
Absenteeism: days off work since baseline7.9 (23.5)4.3 (14.5)0.47 (0.24 to 0.92)f.03
Presenteeism: reduced productivity at work2.2 (2.5)2.0 (2.5)0.17 (−0.42 to 0.75)b.57
Satisfaction with care received, No. (%)g
Satisfied161 (71)215 (70)1.15 (0.84 to 1.59)d.39
Neutral23 (10)41 (13)
Not satisfied44 (19)52 (17)
Satisfaction with results of care, No. (%)g
Very satisfied/satisfied133 (59)209 (70)1.50 (1.04 to 2.16)d.03
Neutral39 (17)45 (15)
Not satisfied52 (23)46 (15)
  • CSQ-CAT = Coping Strategies Questionnaire – CATastrophizing subscale; HADS = Hospital Anxiety and Depression Scale; MCID = minimal clinically important difference; MCS = Mental Component Subscale; PCS = Physical Component Subscale; PSEQ = Pain Self-Efficacy Questionnaire; RMDQ = Roland and Morris Disability Questionnaire; SF-12 = Short Form 12; TSK = Tampa Scale of Kinesiophobia.

  • Note: Values are mean (SD) unless otherwise noted.

  • a Effect estimate and 95% confidence interval derived by regression analyses adjusted for age, sex, general practice, baseline RMDQ, duration of pain, and corresponding baseline value.

  • b Mean difference derived by linear regression.

  • c Based on an MCID (≥30% reduction in RMDQ score from baseline and rating of “completely recovered” or “much better” or “better” according to the global change question).

  • d Odds ratio derived by binary/ordinal logistic regression.

  • e Based on 290 of 547 respondents who reported being currently employed at 6-month follow-up.

  • f Incidence rate ratio derived by robust Poisson regression.

  • g Based on 536 respondents for the care received question and 524 for the results of care question at the 6-month follow-up.